AGP Picks
View all

Global Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.

Press releases published on May 12, 2026

Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
Elevra Lithium Announces Purchase of Moblan Offtake Rights
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
Varonis to Present at Upcoming Investor Conferences
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2026 Guidance
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Astera Labs Announces Second Quarter 2026 Financial Conference Participation
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
TELA Bio Reports First Quarter 2026 Financial Results
Red Cat Announces Proposed Public Offering of Common Stock
Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results
Kura Oncology Reports First Quarter 2026 Financial Results
Aura Biosciences to Participate in Upcoming Investor Conferences
Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity

Share this page:

Sign up for:

Global Tech Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.